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Kinetic behavior of urea is different from that of other water-
soluble compounds: The case of the guanidino compounds.
Background. Although patients with renal failure retain a
large variety of solutes, urea is virtually the only currently ap-
plied marker for adequacy of dialysis. Only a limited number of
other compounds have up until now been investigated regarding
their intradialytic kinetics. Scant data suggest that large solutes
show a kinetic behavior that is different from urea. The question
investigated in this study was whether other small water-soluble
solutes, such as some guanidino compounds, show a kinetic be-
havior comparable or dissimilar to that of urea.
Methods. This study included 7 stable conventional hemodial-
ysis patients without native kidney function undergoing low
flux polysulphone dialysis (F8 and F10HPS). Blood samples
were collected from the inlet and outlet bloodlines immedi-
ately before the dialysis session, after 5, 15, 30, 120 minutes, and
immediately after discontinuation of the session. Plasma con-
centrations of urea, creatinine (CTN), creatine (CT), guanidi-
nosuccinic acid (GSA), guanidinoacetic acid (GAA), guanidine
(G), and methylguanidine (MG) were used to calculate corre-
sponding dialyzer clearances. A two-pool kinetic model was
fitted to the measured plasma concentration profiles, resulting
in the calculation of the perfused volume (V1), the total dis-
tribution volume (Vtot), and the intercompartmental clearance
(K12); solute generation and overall ultrafiltration were deter-
mined independently.
Results. No significant differences were observed between
V1 and K12 for urea (6.4 ± 3.3 L and 822 ± 345mL/min, re-
spectively) and for the guanidino compounds. However, with
respect to Vtot, GSA was distributed in a smaller volume (30.6 ±
4.2 L) compared to urea (42.7 ± 6.0L) (P < 0.001), while CTN,
CT, GAA, G, and MG showed significantly higher volumes
(54.0 ± 5.9 L, 98.0 ± 52.3 L, 123.8 ± 66.9 L, 89.7 ± 21.4 L, 102.6 ±
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33.9 L, respectively; P = 0.004, = 0.033, = 0.003, < 0.001, =
0.001, respectively). These differences resulted in divergent ef-
fective solute removal: 67% (urea), 58% (CTN), 42% (CT),
76% (GSA), 37% (GAA), 43% (G), and 42% (MG).
Conclusion. The kinetics of the guanidino compounds under
study are different from that of urea; hence, urea kinetics are
not representative for the removal of other uremic solutes, even
if they are small and water-soluble like urea.
Urea kinetic modeling has become one of the corner-
stones of estimation of dialysis adequacy. In uncontrolled
studies, urea removal parameters have been related to
morbidity and mortality of dialysis patients [1]. Two re-
cent controlled studies, however, showed that giving more
dialysis, defined as a higher clearance of smaller solutes
like urea, did not improve survival [2, 3].
For that reason, it might be considered that molecules
with a kinetic behavior different from that of urea play
an equal, if not more important, role in the pathophys-
iologic deterioration of patients with renal dysfunction.
Differences in kinetic behavior can be conceived for some
uremic retention solutes that are difficult to remove due
to their high molecular weight and/or lipophilic proper-
ties. However, the kinetic behavior of small water-soluble
molecules may also differ from that of urea, possibly ac-
counting for the failure of urea clearance to predict out-
come, once a certain threshold has been exceeded.
The guanidino compounds are a large group of so-
lutes, resulting from protein and amino acid metabolism.
Among them, only some small and water-soluble guani-
dino compounds were considered in this study: 4
well-known [4–6] uremic retention solutes (creatinine,
guanidinosuccinic acid, guanidine, and methylguanidine)
together with guanidinoacetic acid and creatine, which
show a decreased serum concentration in the patients
included in this study and in nondialyzed patients with
chronic renal insufficiency [6]. Guanidino compounds
can interfere with neuronal [7], cardiovascular [8],
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Table 1. Main characteristics of the patients
Time on Blood Body Total serum Session
dialysis flow weighta proteina duration
Patient no. Sex Age years months mL/min kg Hcta % g/L UF L minutes Dialyzer
1 F 79 76 287 73.8 40 67.2 3.1 240 F8
2 F 53 80 349 95.6 41 72.0 3.2 240 F8
3 M 73 30 318 71.8 37 72.4 4.5 270 F10HPS
4 F 81 97 326 69.8 36 65.9 2.3 240 F10HPS
5 M 56 113 330 70.1 34 57.0 3.5 270 F10HPS
6 M 73 42 350 75.8 33 57.6 4.3 240 F10HPS
7 M 60 106 350 88.4 40 62.2 4.7 270 F8
Mean – 68 78 330 77.9 37 64.9 3.7 253 –
SD – 11 32 23 10.1 3 6.3 0.9 16 –
Abbreviations are: Hct, hematocrit; UF, ultrafiltration; SD, standard deviation.
aPredialysis.
leukocyte [9], platelet [10], and erythrocyte function
[11]. Of note, several of the guanidino compounds have
concentrations relative to normal, which are proportion-
ately much higher than urea [5, 6, 12].
Considering this important contribution of the guani-
dino compounds to clinical disturbances related to the
uremic syndrome, the present study has been undertaken
to quantify their kinetics. Therefore, a two-pool model
was applied for kinetic calculations based on fitting pro-
files of plasma concentrations during hemodialysis. The
kinetic parameters (i.e., perfused volume, total distribu-
tion volume, and intercompartmental clearance) were
compared to the values obtained for urea.
METHODS
Patient and dialysis strategies
The study was performed in 7 stable dialysis patients
(3 women and 4 men) without residual renal function.
The study was approved by the local ethical committee,
and written informed consent was obtained. The patients
were 68 ± 11 years old, and had spent 78 ± 32 months on
dialysis. Conventional two-needle hemodialysis was per-
formed for 253 ± 16 minutes using low-flux polysulphone
dialyzers: F8 (N = 3) and F10HPS (N = 4) (Fresenius
Medical Care, Bad Homburg, Germany). All patients had
a fistula as vascular access. The main characteristics of the
patients and their dialysis sessions are shown in Table 1.
The composition of the dialysate was: 38.5 mmol/L bi-
carbonate, 138 mmol/L sodium, 104 mmol/L chloride,
4 mmol/L acetate, 1.25 mmol/L calcium, and 0.5 mmol/L
magnesium. The dialysate potassium concentration was
adapted to the needs of the patients and ranged from 1 to
3 mmol/L. A constant dialysate flow rate of 500 mL/min
was applied using a Fresenius FO1 or FO3 dialysis ma-
chine. Blood flow rates of 330 ± 23 mL/min and ultrafil-
tration rates of 0.85 ± 0.19 L/h were obtained (Table 1).
Mean Kt/Vurea in this population was 1.77 ± 0.17 by
routine monthly assessment according to the single-pool
Daugirdas formula [13] immediately before the study.
Blood and dialysate sampling
For each patient, blood samples were taken from the
inlet and outlet blood lines immediately before the on-
set of dialysis, after 5, 15, 30, 120 minutes, and im-
mediately after discontinuation of the dialysis session,
without slowing down the blood pump. Blood samples
were immediately centrifuged during 10 minutes at 1900g
(CR 412, Jouan, Saint-Herblain, France), after which the
plasma was stored at −80◦C until analysis. From the out-
let dialysate line, dialysate was sampled after 5, 15, 30,
120 minutes after the start of dialysis, and immediately
before the end of dialysis. From a preliminary study in 2
patients, taking samples at 14 time points during the dial-
ysis session, it was concluded that all investigated solutes
were characterized by a two-pool kinetic behavior. As a
consequence, the number of data points could be limited
to those reported here.
Analyses
Total protein was determined photometrically by
the biuret method (Genesys 10vis; Spectronic, Unicam,
Rochester, NY, USA). Hematocrit was measured with
the capillary centrifugation technique. Urea concentra-
tions were determined with the method of Ceriotti et al
[14]. The concentrations of creatinine (CTN), creatine
(CT), guanidinosuccinic acid (GSA), guanidinoacetic
acid (GAA), guanidine (G), and methylguanidine (MG)
were determined with a Biotronic LC 6001 amino acid an-
alyzer (Biotronik, Maintal, Germany) adapted for guani-
dino compound determination [15].
Kinetic model
A flow chart of the two-pool model used in the present
study is shown in Figure 1. The total distribution volume
(Vtot) was assumed to consist of 2 distinct volumes: the
perfused volume (V1) and the nonperfused (V2). Each
compartment was theoretically characterized by a homo-
geneous solute concentration with variable inputs and
outputs. The solute transport between 2 compartments
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Fig. 1. Flow chart of the two-pool kinetic
model. V1, perfused volume; V2, nonperfused
volume; Vtot, total distribution volume; C1,
concentration in perfused compartment; C2,
concentration in nonperfused compartment;
CPi, plasma concentration at blood inlet; CPo,
plasma concentration at blood outlet; CDi,
concentration at dialysate inlet; CDo, concen-
tration at dialysate outlet; K, dialyzer clear-
ance; K12, intercompartmental clearance; GS,
solute generation rate; QB , dialyzer blood
flow; QD, dialyzer dialysate flow; QUF , ultra-
filtration flow.
was considered to be driven by concentration gradients
(diffusion), and/or pressure gradients (convection). As
a compartment does not necessarily coincide with an
anatomic entity [16], the perfused volume was not taken
a priori equal to the plasma volume, but was assumed not
to be smaller than the predialysis plasma volume, Vplasma.
The latter was calculated from total blood volume as 1/13
of total body weight (BW-kg), followed by subtraction of
the contribution of the predialysis hematocrit, Hct:
Vplasma = BW13 · (1 − Hct) (Equation 1)
From the inlet and outlet plasma concentrations, CPi
and CPo, the blood flow, QB, and the ultrafiltration rate,
QUF, total clearance K (mL/min) was calculated consider-
ing diffusive, as well as convective, contribution to overall
clearance [17]:
K = CPi − CPo
CPi
· QB + CPoCPi · QUF (Equation 2)
For each solute, clearances at different time points
throughout the dialysis session remained stable (standard
deviation less than 3%) so that the mean of these indi-
vidual clearances was used.
The solute generation rate GS (mmol/min) in the in-
terdialytic period, Tinter (min), was assumed equal to the
amount of solutes collected in the dialysate [18]. There-
fore, it was calculated as a function of the solute concen-
tration, CD (mmol/L), in the collected dialysate volume,
VD (L):
GS = VD · CDTinter (Equation 3)
This method of calculating the generation rate excludes
the amount of solutes that is metabolized after genera-
tion in the nonperfused volume. Furthermore, no signif-
icant differences in the kinetic parameters were found
considering generation as taking place in the perfused or
nonperfused compartment. Therefore, although CTN is
known as being generated in the muscles, solute gener-
ation rate was generally considered to take place in the
perfused compartment, a rationale also followed in pre-
vious studies [19]. A similar rationale was followed, as
well, for the other guanidino compounds studied.
Ultrafiltration QUF (0.85 ± 0.19 L/h) was taken into ac-
count to calculate convective clearance (equation 2), and
to vary total distribution volume in time. Ultrafiltration
was assumed to occur in both compartments, dV1/dt and
dV2/dt, in proportion to the compartment volume ratio.
The time variation of the compartment concentration
was, for a particular solute, determined by solving a series
of mass balance equations for both compartments [16,
18]:
{ d(V1C1)
dt = GS − K · C1 + K12 · (C2 − C1)
d(V2C2)
dt = −K12 · (C2 − C1) (Equation 4)
The predialysis concentration in the perfused and
nonperfused compartment was assumed equal to the
predialysis plasma solute concentration. The model, de-
veloped with JSim 1.5 (National Simulation Resource,
Seattle, WA, USA), iteratively solved the mass balance
equations for the complete dialysis session time (either
240 or 270 minutes). The perfused volume, V1 (L), total
distribution volume, Vtot (L), as well as the intercompart-
mental clearance, K12 (mL/min), were calculated from fit-
ting the solution to the measured plasma concentrations.
The JSim Mathematical Modeling Language (MML), fol-
lowing standard mathematic nomenclature, was used to
define the equations of the problem to be solved. The
applied software used the Dopri5 method to solve the
differential equations [20], and the Simplex method was
used to minimize the standard errors on the fitting.
In a preliminary study, our data was also fitted calcu-
lating only 2 kinetic parameters (Vtot and K12), as pro-
posed by the HEMO study [21]. The a priori assumption
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of V1/V2 equal to 1 by 2 for urea, as used in the HEMO
method, resulted in larger standard errors on the fitting
compared to our method. As a consequence of this ob-
servation and the fact that no a priori assumptions can
be made with respect to the guanidino compounds, we
have decided to consider the perfused volume as 1 of the
3 fitting parameters.
In conclusion, dialyzer clearance (K) and solute gener-
ation rate (GS) were calculated from plasma and dialysate
concentrations, respectively. Together with the ultra-
filtration rate (QUF), they were used as known input
parameters in the kinetic model. The sampled concentra-
tions were fitted with a biexponential curve determining
the perfused volume (V1), the total distribution volume
(Vtot), and the intercompartmental clearance (K12). The
volume of the nonperfused compartment (V2) was calcu-
lated from the fitted parameters V1 and Vtot.
Effective solute removal
In analogy with the definition for the urea reduction
ratio, URR, the reduction ratio RR (%) of the guanidino
compounds can be defined as a function of pre- (C1 pre)
and immediate postdialysis concentration (C1 post) in the
perfused compartment:
RR = C1 pre − C1 post
C1 pre
· 100 (Equation 5)
Due to redistribution in the body compartments fol-
lowing dialysis, the effective reduction ratio will be
smaller than calculated with equation 5 if a multicompart-
mental distribution is present. Therefore, concentration
profiles in both compartments were calculated during the
60 minutes following discontinuation of the dialysis ses-
sion using the same kinetic model as mentioned above.
Dialyzer clearance was set equal to zero, while solute
generation was assumed to occur continuously in the per-
fused compartment, according to the same conditions as
accepted before. Solute concentration after 60 minutes
(C1 60post), was calculated from the immediate postdial-
ysis concentration in the perfused volume (C1 post) and
the previously obtained kinetic characteristics. C1 60post
allowed calculating the effective reduction ratio RReff
(%) for the different solutes:
RReff = C1 pre − C1 60postC1 pre · 100 (Equation 6)
To define the removal from the nonperfused compart-
ment, which corresponds to removal from tissues and or-
gans where biological/biochemical activity is displayed,
the effective relative decline of concentration (slope:
delta SC2eff) was calculated from the pre- (C2 pre) and
immediate postdialysis concentration in the nonperfused
volume (C2 post), normalized to a total dialysis session
duration ttotal of 240 minutes:
deltaSC2eff =
(
C2 pre − C2 post
C2 pre
/
240
ttotal
)
· 100
(Equation 7)
Statistical analysis
Data are expressed as mean ± standard deviations.
Correlations between parameters were investigated by
performing linear regression analysis (Pearson). Statisti-
cal analyses were carried out using the Student t test for
unpaired samples on normally distributed populations,
with P < 0.05 as the limit of significant difference.
RESULTS
For the different studied compounds, Figure 2 illus-
trates the concentration profiles in the perfused and non-
perfused compartments as fitted on the measured data
points during dialysis in one of the patients evaluated in
the present study. Compared to urea, the concentration
profiles in the perfused volume for most of the guanidino
compounds show a more pronounced biexponential pro-
file. This corresponds to larger nonperfused volumes (see
below), and is indicated by a steep exponential decline
(according K/V1) when dialysis starts, followed by a gen-
tle exponential slope (determined by K12/Vtot) (e.g., CT,
GAA, G, and MG). The relative distance in between both
curves is a measure for the intercompartmental clearance:
closer curves correspond to a higher rate of solute ex-
change in between both pools, such that concentration
equilibriums are reached more easily (e.g., G and MG).
More importantly, the relative slope of the concentra-
tion curve of the nonperfused compartment (bold line)
offers an idea about the effective clearance from the pa-
tients’ tissues (delta SC2eff). The latter is more efficient
for steeper slopes (e.g., urea, CTN, and GSA) (see below)
(The reader must pay attention to the different scales on
the y-axis as applied for the different solutes).
In Table 2, solute generation rate (GS), dialyzer clear-
ance (K), and the fitted kinetic parameters [perfused vol-
ume (V1), total distribution volume (Vtot), and intercom-
partmental clearance (K12)] are shown for the different
investigated solutes. For urea and creatinine, mean total
distribution volumes were equal to 42.7 ± 6.0 L and 54.0 ±
5.9 L, while the perfused compartment volumes were 6.4
± 3.3 L and 7.6 ± 3.4 L, respectively. The perfused and
total distribution volumes of the guanidino compounds
were 4.2 ± 1.3 L and 98.0 ± 52.3 L (CT), 5.7 ± 1.9 L
and 30.6 ± 4.2 L (GSA), 8.1 ± 5.1 L and 123.8 ± 66.9 L
(GAA), 8.4 ± 6.2 L and 89.7 ± 21.4 L (G), and 8.0 ± 3.7 L
and 102.6 ± 33.9 L (MG). Total distribution volumes nor-
malized for patient’s body weight were 0.55 ± 0.09 L/kg
(urea), 0.70 ± 0.09 L/kg (CTN), 1.38 ± 0.72 L/kg (CT),
0.39 ± 0.05 L/kg (GSA), 1.65 ± 0.93 L/kg (GAA), 1.17 ±
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Fig. 2. Concentration profiles (mmol/L) during the dialysis session of urea and the different investigated guanidino compounds in a representative
patient. The asterisks (∗) plot the measured data, while the thin and bold line represents the fitted concentration profiles in the perfused (V1) and
nonperfused compartment (V2), respectively. The angle in between the dotted lines is a measure for the solute removed from the nonperfused
compartment (delta SC2eff).
0.34 L/kg (G), and 1.32 ± 0.39 L/kg (MG). No signifi-
cant differences were observed between the volumes of
the perfused compartment among all the compounds un-
der study. With respect to the total distribution volumes,
however, there were significant differences between the
values for urea and those for CTN (P = 0.004), CT (P =
0.033), GSA (P < 0.001), GAA (P = 0.003), G (P <
0.001), and MG (P = 0.001) (Table 3). While most
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Table 2. Kinetic modeling parameters
GS V1 Vtot Vtot/BW K K12
Compound mmol/24h L L L/kg mL/min mL/min
Urea 310 ± 86 6.4 ± 3.3 42.7 ± 6.0 0.55 ± 0.09 261 ± 17 822 ± 345
CTN 9.83 ± 3.90 7.6 ± 3.4 54.0 ± 5.9 0.70 ± 0.09 264 ± 14 618 ± 113
CT 0.557 ± 0.354 4.2 ± 1.3 98.0 ± 52.3 1.38 ± 0.72 257 ± 21 588 ± 84
GSA 0.087 ± 0.037 5.7 ± 1.9 30.6 ± 4.2 0.39 ± 0.05 235 ± 29 625 ± 138
GAA 0.019 ± 0.006 8.1 ± 5.1 123.8 ± 66.9 1.65 ± 0.93 266 ± 16 715 ± 288
G 0.021 ± 0.004 8.4 ± 6.2 89.7 ± 21.4 1.17 ± 0.34 267 ± 25 918 ± 362
MG 0.046 ± 0.028 8.0 ± 3.7 102.6 ± 33.9 1.32 ± 0.39 278 ± 15 1025 ± 498
Abbreviations are: GS, solute generation rate; V1, perfused volume; Vtot, total distribution volume; Vtot/BW, total distribution volume normalized for body weight;
K, solute clearance; K12, intercompartmental clearance; CTN, creatinine; CT, creatine; GSA, guanidinosuccinic acid; GAA, guanidinoacetic acid; G, guanidine; MG,
methylguanidine.
Table 3. Levels of significance for the differences between modeled parameters of the different compounds
Urea CTN CT GSA GAA G MG
Urea Vtot\K NS NS NS NS NS 0.026
CTN 0.004 Vtot\K NS 0.040 NS NS NS
CT 0.033 NS Vtot\K NS NS NS 0.044
GSA <0.001 <0.001 0.017 Vtot\K 0.030 NS 0.005
GAA 0.003 0.005 NS 0.003 Vtot\K NS NS
G <0.001 0.001 NS <0.001 NS Vtot\K NS
MG 0.001 0.001 NS <0.001 NS NS Vtot\K
P levels for dialyzer clearance K above the diagonal and for total distribution volume Vtot below the diagonal; no significant differences were found for the perfused
compartment V1; no significant differences were found for the intercompartmental clearance K12, except between G and GSA (P = 0.017).
guanidino compounds showed a total distribution volume
exceeding that of urea, GSA was distributed in a smaller
volume. Analogous significant differences were observed
for the total distribution volume normalized for body
weight between urea and CTN (P = 0.008), CT (P =
0.017), GSA (P = 0.001), GAA (P = 0.003), G (P <
0.001), and MG (P < 0.001). In addition to the differences
with urea, total distribution volumes of CTN and GSA
were significantly lower compared to the other guani-
dino compounds. Moreover, Vtot for GSA was remark-
ably lower (P < 0.001) than for CTN. As a consequence,
CT, GAA, G, and MG showed a similar behavior, while
other compounds (urea, CTN, and GSA) each had a spe-
cific behavioral pattern.
No significant differences were observed between the
intercompartmental clearances among the investigated
compounds, except between the K12 for G and GSA
(P = 0.017). With respect to the dialyzer clearance of
the different solutes, only some singular significant dif-
ferences were found (Table 3).
The pre- and postdialysis concentrations in the per-
fused volume, as well as the reduction ratios RR and
RReff, as calculated with equations 5 and 6, are specified
in Table 4. With the immediate postdialysis concentra-
tion, RR values were 75 ± 4% (urea), 69 ± 4% (CTN),
59 ± 12% (CT), 82 ± 5% (GSA), 53 ± 12% (GAA), 56 ±
6% (G), and 55 ± 8% (MG). Applying the perfused
volume concentration corresponding to the 60th minute
postdialysis, however, RReff values of 67 ± 4% (urea),
58 ± 6% (CTN), 42 ± 16% (CT), 76 ± 6% (GSA), 37 ±
14% (GAA), 43 ± 7% (G), and 42 ± 12% (MG) were
found. There was a significant difference between the RR
and RReff values for urea and those for CTN (P = 0.024
and 0.006), CT (P = 0.033 and 0.017), GSA (P = 0.014
and 0.006), GAA (P = 0.005 and 0.003), G (P < 0.001
both), and MG (P < 0.001 both). While all other guani-
dino compounds showed RR and RReff values lower than
urea, GSA was removed more efficiently compared to
urea.
Solute removal from the nonperfused compartment
(delta SC2eff), indicated by the slope of the correspond-
ing concentration curve in Figure 2, as explained above,
is also shown in Table 4 for the different investigated
compounds. Solute removal of GSA (delta SC2eff = 73 ±
4%) was significantly more pronounced as compared to
urea (65 ± 7%) (P = 0.019), while GAA (34 ± 15%), G
(41 ± 8%), and MG (40 ± 12%) were significantly less
efficiently removed from the nonperfused compartment
(P = 0.005, < 0.001, and < 0.001, respectively).
No correlations were found between urea and the
guanidino compounds for the different model parame-
ters (V1, Vtot, K, and K12) or for the derived parameters
(RR, RReff, and delta SC2eff). RR, RReff, and delta SC2eff
percentages, however, were found to correlate inversely
with total distribution volumes (R = −0.97–P < 0.001 for
RR and RReff, and R = −0.94–P = 0.002 for delta SC2eff)
(Fig. 3). As a consequence, solute removal of CT, GAA,
G, and MG, characterized by similar and large total dis-
tribution volumes, occurred with a comparable efficiency,
which was smaller than that of urea, CTN, and GSA. Con-
sidering the mean parameter values as shown in Table 2,
dialyzer clearance, K, and intercompartmental clearance,
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Table 4. Molecular weight (MW), reduction ratio (RR), corrected reduction ratio (RReff), and the concentration decline in the nonperfused
compartment (delta SC2eff) for the different compounds
Compound MW Da C1 pre lmol/L C1 post lmol/L C1 60post lmol/L RR % RReff % delta SC2eff %
Urea 60 24 ± 9a 6.1 ± 2.6a 8.0 ± 3.3a 75 ± 4 67 ± 4 65 ± 7
CTN 113 1015 ± 286 312 ± 93 427 ± 138 69 ± 4b 58 ± 6b 55 ± 3b
CT 131 50 ± 42 24 ± 14 35 ± 22 59 ± 12b 42 ± 16b 52 ± 28
GSA 175 12.0 ± 4.4 2.1 ± 0.9 2.8 ± 1.1 82 ± 5b 76 ± 6b 73 ± 4b
GAA 117 1.7 ± 0.6 0.8 ± 0.1 1.1 ± 0.2 53 ± 12b 37 ± 14b 34 ± 15b
G 59 1.8 ± 0.3 0.8 ± 0.1 1.0 ± 0.2 56 ± 6b 43 ± 7b 41 ± 8b
MG 73 3.7 ± 2.0 0.2 ± 0.1 2.3 ± 1.4 55 ± 8b 42 ± 12b 40 ± 12b
Abbreviations are: C1 pre, predialysis plasma concentration; C1 post, postdialysis plasma concentration; C1 60post, plasma concentration 60 minutes after dialysis;
CTN, creatinine; CT, creatine; GSA, guanidinosuccinic acid; GAA, guanidinoacetic acid; G, guanidine; MG, methylguanidine.
aUrea concentration in mmol/L.
bP < 0.05 compared to urea.
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K12, were negatively correlated with solute molecular
weight, and correlation coefficients R were equal to –
0.78 and –0.79 (P = 0.037 and P = 0.033) (Fig. 4). The
perfused and total distribution volume, however, did not
correlate with solute molecular weight.
DISCUSSION
The present study sets out to evaluate the kinetic char-
acteristics of several guanidino compounds, and to com-
pare them with a standard marker of dialysis adequacy,
urea. For this purpose, a two-pool kinetic model was ap-
plied, as plasma concentrations during dialysis showed
a biexponential profile. For each solute, both differen-
tial equations were solved using 3 parameters to fit the
measured data: the perfused compartment volume, V1,
total distribution volume, Vtot, and the intercompartmen-
tal clearance, K12. The differences in kinetic behavior can
be determined by assessing the relationship between dia-
lyzer clearance, intercompartmental clearance, and com-
partment volumes for each solute.
The most striking results of this study are: first, most of
the studied guanidino compounds show a kinetic behav-
ior that is different from that of urea; second, the distri-
300
250
200
150
100
K,
 m
L/
m
in
50 100 150 200
Molecular weight, Da
400
600
800
1000
1200
K
12
,
 m
L/m
in
R = −0.79
R = −0.78
Fig. 4. Correlations between solute molecular weight and dialyzer
clearance K (+), and intercompartmental clearance K12 (×).
bution volume of CT, GAA, G, and MG is substantially
larger than that of urea, while the distribution volume of
GSA is significantly smaller; third, these differences oc-
cur in spite of similar dialyzer and intercompartmental
clearance values; fourth, urea does not correlate with the
guanidino compounds for any of the kinetic parameters.
Although the plasma and organ systems of patients
with renal failure contain a large amount of retention
compounds [12], many of which have a potential for tox-
icity, data on solute removal pattern during dialysis have
been collected only for a limited number of compounds.
In addition, these studies do not always contain a com-
parison regarding the kinetic behavior. Our study essen-
tially emanated from the question whether urea, which is
a currently applied marker for dialysis adequacy, shows
a kinetic behavior that is comparable to that of guani-
dino compounds. This question was especially addressed
since the guanidino compounds are, like urea, degrada-
tion products from proteins and amino acids, with an al-
most similar dialyzer clearance and molecular weight, and
the same hydrophilic physicochemical characteristics.
Most serum guanidino compound concentrations are
increased in hemodialysis patients [4, 5] and in nondia-
lyzed patients with chronic renal failure [6]. Mean uremic
GSA and MG serum levels are up to 200 and 100 times
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higher, respectively, compared to controls, while guani-
dine and creatinine concentrations are approximately 10
times increased [5, 6, 12]. For urea, the corresponding
increase is only 6-fold [12]. The highest absolute concen-
trations were found for urea, creatinine, and creatine. A
high solute concentration, however, does not necessarily
imply a strong biologic toxicity. While urea and creatinine
have a rather limited biologic toxicity, several guanidino
compounds, on the contrary, are related to neurotoxic-
ity [7], cardiovascular [8], and hematologic complications
[10, 11] and alterations of leukocyte function [9]. GSA has
been associated to uremic bleeding diathesis [10], and
contributes to the toxic phenomena affecting the func-
tion of the central nervous system [22]. Moreover, it has,
together with G, been held responsible for hemolysis [11,
23]. MG and G have been suggested to relate to uremic
polyneuropathy [23], and are considered to be epilepto-
genic [24]. Despite their potential for toxicity, guanidino
compound kinetics during dialysis have never been the
subject of investigation.
In one study, it was indirectly suggested that
guanidino compounds display a different intradialytic
behavior compared to urea, suggesting differences in
compartmental behavior [25]. The present study corrob-
orates this impression by direct calculations.
As can be observed from Table 2 and Figure 2, guanidi-
noacetic acid, methylguanidine, and guanidine show a re-
markable similarity for the 4 model parameters: perfused
and nonperfused volume, and dialyzer and intercompart-
mental clearances. Although their dialyzer clearance is
similar to (for GAA and G) or even higher (for MG) than
that of urea, the effective removal, expressed by RReff, is
significantly lower than for urea (Table 4). This potential
for different removal behavior is mainly attributable to
the significantly larger nonperfused volume for GAA, G,
and MG. As a consequence, GAA, G, and MG concen-
trations diminish only slightly in the nonperfused com-
partment, as indicated by their significantly smaller delta
SC2eff values, in spite of similar speed of redistribution be-
tween both pools. It should be remarked, however, that
CT and GAA, the precursor of CT, both play an impor-
tant role with respect to the energy metabolism. As a
consequence, the larger distribution volume, as found for
both solutes, must be considered as a positive feature in
avoiding unwanted solute deficiency caused by dialysis.
Guanidinosuccinic acid, on the contrary, is distributed
in a much smaller volume, while it is, however, char-
acterized by an analogous dialyzer clearance as urea.
Although intercompartmental solute transport is signif-
icantly slower than for guanidine (G), GSA shows a ki-
netic behavior approaching that of a single-pool model
(Fig. 2). As a consequence, effective clearance is highly
adequate, even compared to urea.
Up until now, few kinetic analyses have been under-
taken for other molecules than urea. Some of those
have concentrated on b2-microglobulin, which has a rel-
atively high molecular weight compared to urea and the
studied guanidino compounds [26, 27]. Not surprisingly,
molecules like b2-microglobulin show a kinetic behavior
different from urea, essentially attributable to the resis-
tance imposed by their molecular weight on the transfer
from one compartment to another. Surprisingly, in the
present study, we found an aberrant kinetic behavior for
the guanidino compounds, which are small and water-
soluble like urea.
In previous studies, applying less refined tools for the
estimation of intradialytic behavior, it has been shown
that urea removal did not correlate with removal of sev-
eral protein-bound compounds [28, 29]. In addition, a
similar discrepancy was shown for urea and three small
water-soluble compounds, phosphate [30, 31], xanthine,
and hypoxanthine [28, 29]. The latter 3 solutes are known
to interfere with biological/biochemical functions [32, 33],
in contrast to urea, for which few interactions are known,
even at the clinical level [2]. Our data add to the percep-
tion that urea is not representative as a marker for the re-
moval of other uremic solutes. According to the present
data, this is even true for equally small and water-soluble
compounds.
Why do small water-soluble compounds behave dif-
ferently from urea? Virtually none of uremic retention
solutes kinetically behave like urea, even not creatinine,
as also demonstrated by our own data. Previous a pri-
ori studies, assuming a total distribution volume equal
to that of urea [19], found intercompartmental CTN
transport about half as efficient as that of urea. Without
preliminary assumptions, we found a significantly larger
total distribution volume for CTN, while no difference
was found between the intercompartmental clearances.
Both approaches for CTN kinetic modeling, however, im-
ply a lower effective clearance, which is reflected by sig-
nificantly lower RReff and delta SC2eff values (Table 4),
as compared to urea. In a seminal study, Langsdorf et
al [34] demonstrated that removal of creatinine and uric
acid, 2 small water-soluble compounds, from intracellu-
lar to extracellular, was hampered in dialysis patients as
compared to urea. These data suggest that the transfer
of molecules through the cell membrane is restricted by
other uremic solutes, perhaps due to the induction of
structural changes.
Originally, urea kinetics were mainly modeled using a
single-pool model that allows an easy derivation of the
dialysis adequacy parameter Kt/V [35]. At a later stage,
corrections were introduced accounting for the varying
distribution volume during dialysis due to ultrafiltration
[36]. According to recent data [18, 19, 37, 38], the inter-
pretation of urea kinetics is most accurate when a two-
pool kinetic model is applied. Although most previously
performed two-pool urea kinetic studies used different
a priori assumptions with respect to total distribution
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volume and intercompartmental clearance, our ap-
proach, based on fitting those parameters, results in anal-
ogous conclusions. First, we found a mean urea total dis-
tribution volume of 55% of mean body weight (Table
1), which closely corresponds with the theoretic value of
total body water (56–58% of BW) [16, 37]. Second, our
intercompartmental urea clearance (822 ±345 mL/min)
is in good agreement with previous publications reporting
K12 values ranging from 700 up to 960 mL/min [18, 19].
Furthermore, it should be remarked that our calculated
effective reduction ratio is comparable to the results of
previous clinical studies [39].
Finally, the question should be raised whether the pre-
sented data indicate that follow-up of urea removal in
dialysis patients is irrelevant? Two recent studies showed
no differences in survival, while 2 different levels of urea
removal were pursued [2, 3]. Although observational,
other studies, however, highlight the value of estimat-
ing urea removal as an index of dialysis adequacy [1, 40].
Therefore, the conclusion of the present study is rather
that, apart from urea, we should consider that many other
changes occur in uremia and dialysis, and that not all of
them are representatively reflected by urea kinetics, even
when considering other small water-soluble compounds
such as the guanidino compounds.
CONCLUSION
Because urea is virtually the only clinically applied
marker for adequacy of dialysis, few analyses have con-
centrated on the intradialytic kinetic behavior of other
uremic solutes. While scant data suggest that large solutes
show a kinetic behavior different from urea, the question
investigated in this study is whether other small water-
soluble compounds, such as the guanidino compounds
studied here, show a kinetic behavior that is compara-
ble or not to that of urea. As creatinine, creatine, guani-
dinoacetic acid, guanidine, and methylguanidine have a
significantly larger distribution volume compared to urea,
those compounds are removed less efficiently from the
body than urea. Guanidinosuccinic acid, on the contrary,
characterized by a significantly smaller distribution vol-
ume, is removed more efficiently than urea. In conclusion,
the kinetics of the guanidino compounds under study are
different from that of urea; hence, urea kinetics are not
representative for the removal of other uremic solutes,
even small and water-soluble uremic solutes.
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